AHF 0.00% 2.8¢ australian dairy nutritionals limited

Questions answered. Front foot initiative. So, score this as a...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,941 Posts.
    lightbulb Created with Sketch. 147
    Questions answered. Front foot initiative. So, score this as a plus to management.

    The $1 milk issue was well known and had previously been ventilated by management. The H18 results (particularly for CDC) also partially reflected this.

    Going forward, the budgeted exposure is stated as follows:
    "In the Group’s current budget forecasts for the ensuing 12 months the budgeted sales to Aussie Farmers Direct accounted for less than 5% of total sales expected."

    What's not explained is if this refers to the (*) CDC segment only, so circa $12.4M if H18 annualised (excluding any on-boarding of customers), or the (*) whole of business segment, in which case, circa $21.25M if using H18 annualised.

    Add in for 5% growth (an estimate), and the figures here would become:
    - CDC = $13.0M (so, if AFD @5%, then $651,000, or ~$54,000 monthly). The AFD exposure of $90,000, assuming this approach, therefore infers ~7 weeks of trading.
    - AHF (whole) = 22.3M (so, if AFD @5%, then $1.12M, or ~$93,000 monthly). The AFD exposure of $90,000, assuming this approach, therefore infers one month's worth of trading.

    Most of the loss however would have been in reference to the higher yielding products with yoghurt as the primary example here.

    So, whilst not a material impact (depending upon which analysis is applied), the hit to CDC (already down by a considerable extent), particularly in the higher margin areas, remains concerning. CDC is still in decline at the moment and the risk of impairment (NWS the H18 results) remains real. If the on-boarding of customers either (*) does not replace already crest fallen revenue, or (*) grow the business segment, or (*) reinflate CDC's operating margins quite soon (before F18 is due), then the impairment risk will accelerate, not abate.

    The immediate, past driven exposure is minimal (that's correct, based on the announcement made), but the future focused exposure remains to be seen as now they have to replace either a $650K customer or a $1.120M customer which was now apparently functioning in the higher yielding segments of the supply offering (refer, ASX 24/10 re: yoghurt supply)
    Last edited by Grant62: 06/03/18
 
watchlist Created with Sketch. Add AHF (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $12.63M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $45.83K 1.581M

Buyers (Bids)

No. Vol. Price($)
1 63348 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 63918 1
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
AHF (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.